To explore whether the FOXK2 acetylation status affected the chemosensitivity of cancer cells, shFOXK2‐ovNC, shFOXK2‐ovWT and shFOXK2‐ovK223R cells were treated with cisplatin or doxorubicin for 3–4 days. Here, FOXK2 is linked to cancer.